If the French government is able to deliver, pharmaceutical companies can look forward to potentiall...
Read moreCancer drug prices are rising rapidly, and profit margins for pharmaceutical companies reach upwards...
Read moreDetermine the potential price and reimbursement status of a prospective business development asset.
Read moreUnderstanding payer value and evidence requirements to secure pricing and reimbursement for an oncol...
Read moreSupporting in identifying and obtaining payer scientific advice to inform a Phase III trial design.
Read moreEnabled a biotech to achieve its targets by provision of expert pricing support during a company res...
Read moreReview of secondary literature and clinical trial databases to understand payer willingness to pay.
Read moreThe collaboration with the Ethical Medicines Industry Group (EMIG) will help bring greater understan...
Read moreThe only CAR-T cell therapy available for NHS patients in England and Wales for two distinct blood c...
Read moreOverall, the 2019 Voluntary Scheme has taken significant measures to reduce the time taken for patie...
Read more